Real-World Outcomes in Fingolimod-Treated Patients With Multiple Sclerosis in the Czech Republic: Results From the 12-Month GOLEMS Study

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-016-0471-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Characteristics and Outcomes of Patients Treated With Apremilast in the Real World: Results From the APPRECIATE Study

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2020English

Pnd10 - Genius Rwe Study (Fingolimod Real World Evidence Italian Multicenter Observational Study in Multiple Sclerosis)preliminary Results

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

Severe CD4 Lymphocytopenia in Patients With Multiple Sclerosis Treated With Fingolimod

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Real-World Tocilizumab Use in Patients With Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study

Rheumatology and Therapy
2018English

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

Cryptococcal Meningoencephalitis Treated With Fingolimod in a Patient With Multiple Sclerosis

Turkiye Klinikleri Journal of Case Reports
2019English

Pnd116 - A Three Month Interim Analysis of Fingolimod Treatment Adherence for Relapsing Remitting Multiple Sclerosis in the Uk: The Patient Reported Outcomes With Fingolimod in Local Experience (Profile) Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod

JAMA Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy